A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors
首个靶向FcγRIIB的单克隆抗体（BI-1607）：HER2阳性晚期实体瘤患者的临床前数据和首次人体研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1348
Cortés, Javier; Priego, Araceli; Garralda, Elena; Rojas, Katerin; Lord, Simon R; Goetze, Thorsten O; Kuemmel, Sherko; Crabb, Simon J; Parra-Guillen, Zinnia P; Borggren, Marie; Karlsson, Ingrid; Lindahl, Danijela; Mårtensson, Linda; Oldham, Robert; Ropenga, Anna; Teige, Ingrid; Wallin, Johan; Frendeus, Björn; McAllister, Andres
